Member Info for AquaeSulis01

Sounds like a pretty good excuse to me and one of the advantages of an in-store presence over online with the former acting as a subsequent catalyst for the latter also explains why Skinbio have not unilaterally launched axisbiotix-ac online themselves.

In-store shelf wobblers are attention-grabbing promotional signs attached to a shelf's edge via a flexible strip, causing them to "wobble" or move slightly to catch the eye of shoppers. They are a type of point-of-purchase (POP) marketing tool used to draw attention to specific products, special offers, or price changes.

How they work

Adhesive strip: A flexible, adhesive strip sticks to the edge of a shelf.

Protruding sign: A printed sign is attached to the strip and extends out over the aisle.

Movement: The flexible strip causes the sign to move or "wobble" with the slightest breeze or from a passing person, making it stand out from stationary signage.

Why they are used

Increased visibility: The movement helps the sign stand out and grab a customer's attention as they walk down the aisle.

Boost sales: Shelf wobblers can increase impulse buying and have been shown to boost sales.

Promote offers: They are ideal for promoting special offers, new products, or products on clearance.

Provide information: They can display key product details like prices, discounts, or even QR codes linking to more information.

Customizable: They are often custom-printed and can be designed in various shapes, sizes, and colors to fit a brand's needs.

Cheers elric, let's hope they are delivered to the Superdrug stores soon. https://www.shelfwobblers.co.uk/

Which Chair is that Fox?

Timely and unambiguous Comms are a big concern

Simon leaving , yet to make his mark so no concern

Opti fire selling to keep their own lights on; no concern in fact explains in part the subdued sp in spite of continued big purchases from MD

Chances of MD being unhappy with SA for providing the opportunity to purchase such a large holding at bargain prices and therefore supporting Bazzaman; zero

Https://find-and-update.company-information.service.gov.uk/company/09632164/filing-history

here even :)

He has bigpunt

chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/https://s3.eu-west-2.amazonaws.com/document-api-images-live.ch.gov.uk/docs/2vOqQzi3ZWhD7Yscn7_bSD4SzBB-RsT9jVjuwk6ZTxs/application-pdf?X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=ASIAWRGBDBV3PXQ6D4CZ%2F20251014%2Feu-west-2%2Fs3%2Faws4_request&X-Amz-Date=20251014T085825Z&X-Amz-Expires=60&X-Amz-Security-Token=IQoJb3JpZ2luX2VjELH%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEaCWV1LXdlc3QtMiJHMEUCIQDX06BBSy%2BR9jeFKUuryfrhAwc10D9AvQ7tKQni42d27gIgTBrxreBYWZc4HXfP2PDAMgZmjfu5RqpkHaHHFq552NwqgQQIWRAFGgw0NDkyMjkwMzI4MjIiDNok3Sz%2FKHx1tKgGzCreA1OQ1y9its7F4K3SAwl3yT%2Bm5WYfN4ljhvmFJRAa3FQ02y2QCcbB%2Bw5v5yY%2FweVzFJ6lJvNKLP%2B3ewurKdre4DQct51Q65ZJbJ5UZe1k4A7MXbpfzJSAbR6qERDbAcpu1FBw0ihOc3W6K1kXkqwnx2pcuF89KcspiBy%2BLRKohUOVXdXrtz6qzgRYllNwaLiHDvGSfBfKntBwjPa93YEaoXE6H4z4fzhUhKfDJhvhskyk7ou6s8ISuiQcs%2FdmNTW9boM1hHx2HsqUIyXcgxlqBQQilMbXryyNGBbKUjrbhL5zLs9F8C6X3nPVXGKYbKa4WNcOicrOn6a59au03T%2Fj7pegBpM%2FIcjz8xh8NsHdLFUiPSMRq1MW%2BoKSHSO2Eo%2FvrOabwGe%2BXQRJRuXK1sK3gAp26DdthbKEIUwLfmfB2XsyVggHGCUEdhxn8iRX0jXUTbFpBdIBGAeAQw%2F%2BvrPFYdbud4s6g1ci8HC8msuliaDMiOldQkHvxVHJKfpR3kEAknId6yO%2BZvbVe%2B75GWAof61KkoZkwvBxMACnaELfs4%2BOXmWMreBQiDCX4%2FjzxptfUHq5noB%2BIKuv7sBlDmxenTndPxhoUwbpkPQZjrzr3pSPKfiqCD9HlC4VjuV%2BHO4wxI%2B4xwY6pQHSpNskXHxjrFadXuaJU7j05KTr7rTv9gwXTheKJQ01i5JcgfpKhAtfO0%2BKa7W%2F0KM9JQXxv3k3we2ntsWpDWaiY7vV78EgECbKtTZzsN8KDMvSjp2kEssibjKh2CrQWRyEOGtIn%2FT4sp3NsLTp%2BkhJeQHqkDQ0V%2FeKZoLafahIOj%2Fr%2FgSAwUSS6mmytegF9CgmUk6NZFVQCGKsOvDIPGU%2F75xW0lo%3D&X-Amz-SignedHeaders=host&response-content-disposition=inline%3Bfilename%3D%2209632164_tm01_2025-10-14.pdf%22&X-Amz-Signature=44206035202a9350302b1a65a19a93a26012d12768ffda2b4e194d74dd26fd3d

No doubt Dixon has both you and thecontender on speed dial as Statler and Waldorf

AI is just picking up on the products that Croda have created as examples for their Customers. Try a follow-up question asking which stores you can buy the products in

At this rate there is a good chance that products containing Zenakine will be visible in stores sooner than Axisbiotix.

Despite the formal launch of AxisBiotix™ products in select Superdrug stores, there is currently no evidence of active in-store advertising, promotional signage, or digital campaigns associated with AxisBiotix at any Superdrug location. Here's what the data shows:

🧾 What’s Confirmed:

- Product Placement: SkinBioTherapeutics confirmed delivery of stock and packaging to Superdrug stores in early October 2025.

- Commercial Agreement: A two-year exclusive UK retail deal was signed in June 2025.

- Store List: Cardiff Queens West and Cardiff St Davids are among the confirmed launch sites.

🚫 What’s Missing:

- No Verified Advertising: There are no press releases, social media posts, or retail-facing campaigns showing AxisBiotix™ shelf displays, posters, or promotional materials in Superdrug stores.

- No Visual Evidence: No photos, influencer content, or customer sightings have surfaced to confirm visibility or engagement.

- No Digital Promotion: Superdrug’s website and social channels currently show no mention of AxisBiotix™.

🧩 Strategic Implication:

This suggests the rollout is logistical, not promotional — product may be shelved but not actively marketed. That could reflect:

- A soft launch to test uptake before broader visibility.

- Delays in Superdrug’s commercial team executing shelf placement and signage.

- A strategic choice to avoid early promotional spend until Spring 2026’s full rollout.

Had a friend visit Weston Super Mare superdrug and they hadn't heard of axisbiotix.

Different role altogether. Emily assumed Manprit's financial duties whilst Simon appears to have been brought in for his mergers and acquisitions experience and shareholders have made it clear they do not wish to see any further acquisitions for the foreseeable future.

Thought the COO post was newly created unless you know better?

The term "a nurse's minute" is a figurative expression for a period of time that is intensely busy and can stretch indefinitely, often because nurses are constantly attending to patients' needs. It refers to the reality that even a short period of "a minute" can be a long time when a nurse is dealing with multiple, high-priority tasks simultaneously. Surely all LTH's realise by now that an Anagnostaras-Adams Week = 10,080 nurse's minutes?

Little wonder share price is rising; great presentation

https://www.youtube.com/watch?app=desktop&v=kZuYjz3bLig

Wonder if OHARA the racehorse will fare any better in the 15:05 at Bath?

Thanks Rank and perfectly understand that. I guess many on here would therefore question why a CEO in charge of Staff ex Dermatonics who also have been dealing with Superdrug for years, didn't realise that when in the IM he specifically stated delivery to Superdrug Wk35 to go on the shelves wk 37?

Because it is based on ingredient sells by Croda to their clients not client sales to end customers, the VIPs have had the ingredient for 2 years and Stuart Ashman confirmed first revenue received from Croda by the end of calendar year 2024

Ox, with respect I think the peed off PI's here have overlooked the transformation that has taken place here post the acquisitions and treated the fund raises for those acquisitions as just another keep the lights on exercise. Prior to the acquisitions regular circa £2.5-£3M fund raises were taking place just to keep the lights on, now the recent raises have been to acquire those assets, build revenues and reach break even.

Dermatonics - £2.93M ; £1.68M upfront, and £1.25M earnout over three years (£500K, £500K, £250K)

BTS circa £1.3M

16th Dec 2022 placing to keep the lights on £2.5M

£2.98M operating loss share price over 17p

Nov 2023 placing to keep the lights on £3M

Nov 2023 £2.99M operating loss share price over 19p

02nd Aug 2024 £1.56M raised at 0.10p share price

04th Dec 2024 £2.9M operating loss

16th Jun 2025Raised £4.1M

14th Aug 2025 EBITDA loss £0.3M and £4.8M cash

The contender, it is not all about Croda. There are 125m sufferers of psoriasis worldwide, and axisbiotix-ps has an 80% retention rate amongst the very small number that of heard of it and tried it. The circa 80p per share high that the share price hit was driven by axisbiotix not Croda. So for the first time axisbiotix is about to gain exposure to a much bigger domestic audience via Superdrug and an American audience with the newly acquired NPF accreditation which potentially will lead to a significant recurring revenue stream alongside Croda. The Superdrug launch would not have happened without the Dermatonics acquisition and the contacts that brought, MD recognises the potential hear and has bought in big. So if you believe the story take advantage of the low share price yourselves and if you don't believe this sp is going to take off then why moan if MD takes a different view?

It's not a lovely summary OldsCool it's as blinkered a positive view as Bazzaman's negative diatribe. Today, is not the day to debate SA's performance, for a refreshing change there is some really positive news so let's focus on it and enjoy it